ID
24556
Description
Study ID: 100470 Clinical Study ID: SCO100470 Study Title: A multicentre, randomised, double-blind, parallel group, 24 week study to compare the effect of salmeterol/fluticasone propionate combination product 50/250mcg, with salmeterol 50mcg both delivered twice daily via DISKUS®/ACCUHALER® inhaler on lung function and dyspnoea in subjects with Chronic Obstructive Pulmonary Disease (COPD). Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: N/A Sponsor:GlaxoSmithKline Collaborators: N/A Phase: Phase 3 Study Recruitment Status: Completed Generic Name: fluticasone propionate/salmeterol Trade Name: Serevent Study Indication: Pulmonary Disease, Chronic Obstructive
Keywords
Versions (2)
- 8/6/17 8/6/17 -
- 8/8/17 8/8/17 -
Copyright Holder
GlaxoSmithKline
Uploaded on
August 6, 2017
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
investigational product and blinded study salmeterol/fluticasone propionate combination compared to salmeterol on COPD 100470
investigational product and blinded study salmeterol/fluticasone propionate combination compared to salmeterol on COPD 100470
Description
INVESTIGATIONAL PRODUCT COMPLIANCE
Alias
- UMLS CUI-1
- C0304229
- UMLS CUI-2
- C1321605
Description
date investigational product dispensed
Data type
date
Alias
- UMLS CUI [1,1]
- C0013230
- UMLS CUI [1,2]
- C0808070
Description
Note dose for each Double-Blind Diskus 1, 2, 3 separately.
Data type
integer
Alias
- UMLS CUI [1,1]
- C0678766
- UMLS CUI [1,2]
- C0806020
Description
INVESTIGATIONAL PRODUCT COMPLIANCE
Alias
- UMLS CUI-1
- C0304229
- UMLS CUI-2
- C1321605
Description
date investigational product dispensed
Data type
date
Alias
- UMLS CUI [1,1]
- C0013230
- UMLS CUI [1,2]
- C0808070
Description
Note dose for each Double-Blind Diskus 1, 2, 3 separately.
Data type
integer
Alias
- UMLS CUI [1,1]
- C0678766
- UMLS CUI [1,2]
- C0806020
Description
INVESTIGATIONAL PRODUCT COMPLIANCE
Alias
- UMLS CUI-1
- C0304229
- UMLS CUI-2
- C1321605
Description
date investigational product dispensed
Data type
date
Alias
- UMLS CUI [1,1]
- C0013230
- UMLS CUI [1,2]
- C0808070
Description
Note dose for each Double-Blind Diskus 1, 2, 3 separately.
Data type
integer
Alias
- UMLS CUI [1,1]
- C0678766
- UMLS CUI [1,2]
- C0806020
Description
INVESTIGATIONAL PRODUCT COMPLIANCE
Alias
- UMLS CUI-1
- C0304229
- UMLS CUI-2
- C1321605
Description
date investigational product dispensed
Data type
date
Alias
- UMLS CUI [1,1]
- C0013230
- UMLS CUI [1,2]
- C0808070
Description
Note dose for each Double-Blind Diskus 1, 2, 3 separately.
Data type
integer
Alias
- UMLS CUI [1,1]
- C0678766
- UMLS CUI [1,2]
- C0806020
Description
STATUS OF TREATMENT BLIND
Alias
- UMLS CUI-1
- C0749659
- UMLS CUI-2
- C2347038
Description
treatment status of blinded clinical study
Data type
text
Alias
- UMLS CUI [1,1]
- C0749659
- UMLS CUI [1,2]
- C2347038
Description
if treatment blind broken during the study
Data type
date
Alias
- UMLS CUI [1,1]
- C2347038
- UMLS CUI [1,2]
- C0011008
Description
if treatment blind broken during the study if "other reason", specify that
Data type
text
Alias
- UMLS CUI [1,1]
- C3897431
- UMLS CUI [1,2]
- C2347038
Similar models
investigational product and blinded study salmeterol/fluticasone propionate combination compared to salmeterol on COPD 100470
C1321605 (UMLS CUI-2)
C0808070 (UMLS CUI [1,2])
C0806020 (UMLS CUI [1,2])
C1321605 (UMLS CUI-2)
C0808070 (UMLS CUI [1,2])
C0806020 (UMLS CUI [1,2])
C1321605 (UMLS CUI-2)
C0808070 (UMLS CUI [1,2])
C0806020 (UMLS CUI [1,2])
C1321605 (UMLS CUI-2)
C0808070 (UMLS CUI [1,2])
C0806020 (UMLS CUI [1,2])
C2347038 (UMLS CUI-2)
C2347038 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,2])
C2347038 (UMLS CUI [1,2])